News Daily News FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy L.A. McKeown November 25, 2024
News Daily News SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients L.A. McKeown October 23, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows L.A. McKeown October 09, 2024
News Conference News HFSA 2024 Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM L.A. McKeown October 04, 2024
News Conference News ESC 2024 More Data Diminish Support for Cath Lab Fasting Rules: SCOFF L.A. McKeown September 10, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2024 Caitlin E. Cox September 03, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs L.A. McKeown August 15, 2024
News Daily News Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks L.A. McKeown June 12, 2024
News Daily News As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness L.A. McKeown June 05, 2024
News Conference News SCAI 2024 Radial PCI Benefits Seen in Real-world Analysis, Mirroring RCTs L.A. McKeown May 10, 2024